Capital Markets Day Highlights Renergen Production Milestone and $300M–$700M 2031 EBITDA Target
ASPI sits 20% above its 52-week low of $3.51.
Summary
The Capital Markets Day presentation disclosed that the Renergen helium plant reached its 4 Kelvin target temperature and should begin commercial production by end of September 2026, alongside a $300M–$700M 2031 EBITDA target for the combined group.
Key Events · M&A and Partnerships · ASPI
-
Renergen Plant Reaches 4 Kelvin
The Renergen helium plant in Welkom, South Africa hit its target temperature of 4 Kelvin in August 2026 and is expected to begin commercial production by end of September 2026.
-
2031 EBITDA Target Set at $300M-$700M
Management set a 2031 group EBITDA target range of $300M to $700M, with Renergen expected to achieve 80%+ gross margins at scale due to minimal input costs.
-
Phase 1 Revenue Forecast of $27M
Annualized helium and LNG revenues are expected to be approximately $27M after Phase 1 completion, with first helium exports to international customers anticipated in 2H 2026.
-
Post-Merger Ownership Structure
ASP Isotopes will own 89% of Noble Africa after the reverse merger with ENDRA, leaving a 10-11% free float; customers have expressed interest in ownership stakes or prepayments.
Analysis · ASPI · Industrial Applications And Services
The inaugural Capital Markets Day for ASP Isotopes delivered concrete operational milestones for the pending Noble Africa–ENDRA reverse merger. A critical de-risking event for the merger's core asset: the Renergen helium plant reached its 4 Kelvin target temperature in August and is expected to begin commercial production by end of September 2026. Management also quantified the post-merger ownership structure (89% ASPI / 10–11% free float) and set a 2031 group EBITDA target of $300M–$700M, with Renergen projected at 80%+ gross margins. Phase 1 annualized helium and LNG revenue is forecast at approximately $27M. These specifics move the merger narrative from concept to execution, though the transaction itself remains subject to ENDRA stockholder approval and Form S-4 completion.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ASPI was trading at $4.22 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $647M. The 52-week trading range was $3.51 to $14.49. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.